UPDATE: Oppenheimer Upgrades Alnylam Pharmaceuticals (ALNY) to Outperform
Tweet Send to a Friend
(Updated - November 1, 2021 5:45 AM EDT)
Oppenheimer analyst Leland Gershell upgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Perform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell upgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) from Perform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
